Top Story

New Johnson & Johnson lenses enhance natural eye color

March 5, 2015

ATLANTA – Johnson & Johnson Vision Care launched 1-Day Acuvue Define contact lenses here at SECO.

The lenses are designed to enhance the natural color of the eye, a company representative told Primary Care Optometry News, by using a “limbal ring” to make the sclera look whiter and an “iris-inspired” design pattern.

Business News

STAAR reports net loss for 2014

March 5, 2015
STAAR Surgical reported a GAAP net loss of $8.4 million, or $0.22 on a per diluted share basis, in 2014 compared with a net income of $398,000, or $0.01 on a per diluted…
Business News

Valeant reports growth in fourth quarter, fiscal year 2014 revenues

March 4, 2015
Valeant Pharmaceuticals totaled $8.3 billion in revenue in the fiscal year 2014, a 43% increase from 2013, according to a press release.In the fourth quarter 2014, total…
Breaking News

Oraya receives CE mark extension for IRay to treat choroidal metastases

March 3, 2015
The Oraya IRay radiotherapy system received a CE mark extension for the treatment of choroidal metastases, expanding on prior approval for treatment of wet age-related…
CME
Postoperative Inflammation and Pain

Postoperative Inflammation and Pain: Elimination of the Dynamic Duo to Improve Patient Outcomes

This activity is supported by an educational grant from Bausch + Lomb.

Cataract surgery has improved in both safety and outcomes in recent years. With advances in surgical techniques…
More »
Meeting News Coverage Video
thumbnail for video 4006153210001

VIDEO: Shire executive gives update on company progress

January 23, 2015
WAILEA, Hawaii – At Hawaiian Eye 2015, Robert Dempsey of Shire Pharmaceuticals gives an update on lifitegrast and…
More »
Meeting News Coverage

New Johnson & Johnson lenses enhance natural eye color

March 5, 2015
ATLANTA – Johnson & Johnson Vision Care launched 1-Day Acuvue Define contact lenses here at SECO.The lenses are designed to enhance the…
Business News

STAAR reports net loss for 2014

March 5, 2015
STAAR Surgical reported a GAAP net loss of $8.4 million, or $0.22 on a per diluted share basis, in 2014 compared with a net income of $398,000, or…
Business News

Valeant reports growth in fourth quarter, fiscal year 2014 revenues

March 4, 2015
Valeant Pharmaceuticals totaled $8.3 billion in revenue in the fiscal year 2014, a 43% increase from 2013, according to a press release.In the fourth…
Breaking News

Oraya receives CE mark extension for IRay to treat choroidal metastases

March 3, 2015
The Oraya IRay radiotherapy system received a CE mark extension for the treatment of choroidal metastases, expanding on prior approval for treatment…
Business News

Ophthotech posts $98.2 million net loss in 2014

March 3, 2015
Ophthotech reported a net loss of $98.2 million, or $2.95 per diluted share, in 2014 compared with a net loss of $57 million, or $6.34 per diluted…
Breaking News

Santen seeks European marketing authorization for intravitreal sirolimus

March 3, 2015
The European Medicines Agency has accepted a marketing authorization application from Santen Pharmaceutical for the use of intravitreal sirolimus 440…
FDA News

Shire submits new drug application for lifitegrast

March 2, 2015
Shire submitted a new drug application with the FDA for the approval of its investigational compound lifitegrast for the treatment of dry eye disease…
Business News

Alcon drug meets primary endpoint of change in BCVA for wet AMD

March 2, 2015
RTH258 met its primary endpoint of mean change in best corrected visual acuity from baseline to week 12 in a phase 2 study of patients with…

Nikon agrees to purchase Optos

February 27, 2015
The board of directors of Nikon and Optos have agreed the terms of a recommended cash offer of £259.3 million ($400 million) for the…
Breaking News

Eylea receives approval for macular edema secondary to retinal vein occlusion in Europe

February 26, 2015
The European Commission has approved Eylea for the treatment of visual impairment due to macular edema following retinal vein occlusion, according to…
More Headlines »
morganatic-roan
morganatic-roan